Walgreen Company (NYSE: WAG) reported Q4 EPS of $0.73, $0.01 better than the analyst estimate of $0.72. Revenue for the quarter came in at $17.9 billion versus the consensus estimate of $17.95 billion.

Front-end comparable store sales (those open at least a year) increased 1.6 percent in the fourth quarter, customer traffic in comparable stores decreased 1.9 percent and basket size increased 3.6 percent, while total sales in comparable stores increased 4.6 percent.

Prescription sales, which accounted for 63.9 percent of sales in the quarter, increased 6.1 percent, while prescription sales in comparable stores increased 6.4 percent. The company filled 203 million prescriptions in the quarter, an increase of 8.2 percent over last year’s fourth quarter. Prescriptions filled in comparable stores increased 7.1 percent in the quarter.

For earnings history and earnings-related data on Walgreen Company (WAG) click here.

Earnings Hot Earnings Retail Sales

Barrington Research Upgrades Walgreen (WAG) to OutperformOctober 3, 2013 9:11 AM Walgreen (WAG) Target Raised to $68 at Goldman SachsOctober 1, 2013 3:47 PM Walgreen (WAG) Q4 Margin Doesn't Impress, But Plenty of Positives ReportedOctober 1, 2013 10:22 AM